Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$191.17 - $325.63 $2.1 Million - $3.58 Million
11,000 New
11,000 $3.58 Million
Q2 2023

Jul 26, 2023

SELL
$223.05 - $302.68 $12,044 - $16,344
-54 Reduced 29.03%
132 $37,000
Q1 2023

Apr 12, 2023

SELL
$175.41 - $217.92 $350 - $435
-2 Reduced 1.06%
186 $40,000
Q4 2022

Jan 24, 2023

SELL
$204.38 - $296.82 $51,503 - $74,798
-252 Reduced 57.27%
188 $0
Q3 2022

Oct 13, 2022

BUY
$195.21 - $310.53 $42,946 - $68,316
220 Added 100.0%
440 $122,000
Q1 2022

May 05, 2022

SELL
$127.96 - $207.36 $1.2 Million - $1.95 Million
-9,399 Reduced 97.71%
220 $46,000
Q4 2021

Jan 24, 2022

BUY
$165.13 - $241.83 $1.59 Million - $2.33 Million
9,619 New
9,619 $1.71 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.